 |
Viatris
VTRS
|
$ 12.02
|
14.6 B
|
$ 172 M
|
-4.1
|
1.0
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 10.53
|
6.51 B
|
$ -105 M
|
-10.5
|
9.1
|
$ -1.1
|
 |
 |
Bausch Health Companies
BHC
|
$ 7.32
|
2.67 B
|
$ 3.23 B
|
-6.3
|
0.3
|
$ -1.1
|
 |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.54
|
2.05 B
|
$ -71.4 M
|
-178.2
|
8.2
|
$ -0.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 13.68
|
1.88 B
|
$ 579 M
|
-62.5
|
0.4
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 49.15
|
1.6 B
|
$ 17.6 M
|
-104.8
|
6.6
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.75
|
1.43 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 25.74
|
1.19 B
|
$ -75.6 M
|
-8.8
|
1.7
|
$ -3.0
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 5.75
|
757 M
|
$ 2.42 M
|
-69.0
|
1.4
|
$ -0.1
|
 |
 |
Emergent BioSolutions
EBS
|
$ 12.54
|
642 M
|
$ -238 M
|
-1.5
|
0.5
|
$ -7.5
|
 |
 |
Evolus
EOLS
|
$ 6.81
|
422 M
|
$ -48.4 M
|
-6.3
|
1.6
|
$ -1.1
|
 |
 |
Veru
VERU
|
$ 2.32
|
313 M
|
$ -36.3 M
|
-1.8
|
24.4
|
$ -1.4
|
 |
 |
Solid Biosciences
SLDB
|
$ 5.9
|
241 M
|
$ -115 M
|
-2.6
|
12.1
|
$ -2.3
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 4.49
|
135 M
|
$ -165 M
|
-2.2
|
-115.8
|
$ -1.9
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.26
|
59.9 M
|
$ 1.01 M
|
-12.4
|
0.9
|
$ -0.2
|
 |
 |
Assertio Holdings
ASRT
|
$ 0.66
|
46.9 M
|
$ -3.27 M
|
-3.5
|
0.4
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.58
|
27.8 M
|
$ -72.9 M
|
-1.3
|
11.7
|
$ -0.5
|
 |
 |
China Pharma Holdings
CPHI
|
$ 1.32
|
23.1 M
|
$ -1.98 M
|
-1.4
|
7.3
|
$ -1.2
|
 |
 |
Rockwell Medical
RMTI
|
$ 0.82
|
19.1 M
|
$ 1.12 M
|
-23.2
|
0.2
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 1.64
|
17.1 M
|
$ -3.18 M
|
-35.8
|
7.0
|
$ -0.0
|
 |
 |
ProPhase Labs
PRPH
|
$ 0.69
|
10.9 M
|
$ -14.1 M
|
-0.2
|
0.4
|
$ -0.5
|
 |
 |
cbdMD
YCBD
|
$ 1.66
|
7.16 M
|
$ -1.2 M
|
-0.1
|
0.3
|
$ -11.3
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.58
|
4.44 M
|
$ -5.22 M
|
-1.6
|
0.3
|
$ -2.3
|
 |